From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Cardiology>
  4. Summary and Comment

Is Noninvasive Ventilation Improving Outcomes?

In a large randomized trial, noninvasive ventilation provided no survival advantage to patients with cardiogenic pulmonary edema.

Noninvasive methods of ventilation are being used in patients with acute heart failure, even though the evidence for a net benefit of such a strategy is not very strong. Investigators in the U.K. conducted a large, randomized, multicenter trial to determine if noninvasive ventilation, compared with oxygen administration alone, improves survival in patients with cardiogenic pulmonary edema. Two methods of noninvasive ventilation were compared: continuous positive airway pressure (CPAP) and noninvasive positive-pressure ventilation (NIPPV). The primary endpoint was death or intubation within 7 days after treatment initiation.

A total of 1069 patients with cardiogenic pulmonary edema were randomized to standard oxygen therapy, CPAP, or NIPPV. The patients’ mean age was 78, and about one fifth of them had symptoms of MI. Mean heart rate in all three groups was about 113 beats per minute, and mean systolic blood pressures were about 161 mm Hg.

At 7 days, there was no difference in mortality between noninvasive-ventilation recipients and oxygen-therapy recipients. The composite of death or intubation at 7 days was not significantly different among the three groups, nor was length of hospital stay. More patients discontinued noninvasive ventilation than standard oxygen therapy because of discomfort. By contrast, standard oxygen therapy was discontinued because of worsening blood gas values or respiratory distress more frequently than was noninvasive ventilation.

Comment: The results of this open randomized trial of noninvasive ventilation failed to show a reduction in the risk for death or intubation. The finding that fewer noninvasive-ventilation recipients than oxygen-therapy recipients experienced respiratory distress or metabolic abnormalities did not translate into any clinically meaningful change in outcome. The authors conclude with a "glass-is-half-full" assessment of their findings; nonetheless, this trial provides little support for noninvasive ventilation as an initial approach to patients with acute heart failure.

Harlan M. Krumholz, MD, SM

Published in Journal Watch Cardiology July 9, 2008

Citation(s):

Gray A et al. for the 3CPO Trialists. Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med 2008 Jul 10; 359:142.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Other Perspectives

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2008. Massachusetts Medical Society. All rights reserved.